BioSpring Builds High-Tech Manufacturing Facility for Pharmaceutical Nucleic Acid APIs Dr. Sylvia Wojczewski, CEO of BioSpring: “With our investment in Offenbach, we are setting new standards in nucleic acid drug substance manufacturing,” explained Wojczewski. “In the future, we’ll be able to produce nucleic acids fo…
As the largest provider of emergency care in Texas, Altus Community Healthcare is recognized for its broad network of freestanding emergency rooms and micro-hospitals that deliver fast, patient-centered care across the state. Known for clinical excellence and community responsiveness, Altus continues to grow—driven by…
Axplora is proud to unveil a transformative €35 million expansion at its Farmabios site in Gropello Cairoli, Italy, reinforcing the company’s longstanding commitment to serving the evolving needs of its customers through strategic investment and innovation. This latest investment builds on the €45 million already comm…
Vetter celebrated the start of construction on its new clinical manufacturing site in the Chicago area with an official groundbreaking ceremony. The state-of-the-art facility, which is being built in Des Plaines, Illinois, is expected to be ready for media fill by the end of 2029. This $285 million investment will str…
WuXi XDC Cayman Inc., a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced that the mechanical completion of its manufacturing site at Tuas Biomedical Park in Singapore has been successfully achieved. This milestone signifies that this m…
Sandoz, the global leader in generic and biosimilar medicines, announced the start of construction for a new, state-of-the-art biosimilars production center for sterile product manufacturing in Brnik, Slovenia. This USD 440 million project brings the company’s total planned and ongoing investment in Slovenia to more t…
Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced the official opening of its expanded state-of-the-art manufacturing and logistics facility in Tuas Biomedical Park, Singapore. The event was held in conjunction with the 20th anniversary of Alcon’s operations in Singapore, a me…
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd, recently announced a $90M investment plan to expand two of its U.S. facilities, which are critical to its integrated offering. This ambitious investment underscores the company's commit…
ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, announced the opening of its flagship Cell and Gene Therapy Center of Excellence at the Princeton West Innovation Campus in Hopewell, New Jersey. The 128,000 sq ft GMP facility is purpose-built for manuf…
Hikma Pharmaceuticals USA announces it will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities. This new phase of investment -- America Leans on Hikma: Quality Medicines Manufactured in the USA – will further expand Hikma's well-established domestic capabilities to develop, produ…
Page 23 of 61